A recent study led by a team of researchers at The Johns Hopkins University School of Medicine examining aging mice has provided what is believed to be the first evidence that amyloid beta ...
A recent study led by a team of researchers at The Johns Hopkins University School of Medicine examining aging mice has provided what is believed to be the first evidence that amyloid beta ...
The American Society of Hematology (ASH) released guidelines on the diagnosis of light chain (AL) amyloidosis, a rare and life-threatening disease of the bone marrow. The guidelines, published in the ...
“Today’s announcement represents a major step forward for Immix. We believe this first data cut of U.S. study NEXICART-2 including rapid and deep responses validates our strategy to focus on ...
The American Society of Hematology (ASH) released guidelines on the diagnosis of light chain (AL) amyloidosis, a rare and life-threatening disease of the bone marrow. The guidelines, published in the ...
The American Society of Hematology (ASH) released guidelines on the diagnosis of light chain (AL) amyloidosis, a rare and life-threatening disease of ...
Immix Biopharma (IMMX) announced initial clinical data from the first four patients in the ongoing NEXICART-2U.S. study of sterically-optimized BCMA-targeted chimeric antigen receptor T cell therapy, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results